Company lists · Data refreshed September 2026
Top 25 Early stage biotech investors based in the United Kingdom
RevenueBase identified 79 early stage biotech investors headquartered in the United Kingdom as of September 2026 and tracks 889 professional contacts across them, including 230 with verified work emails. London is the largest hub.
This list covers early stage biotech investors headquartered in the United Kingdom, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 16, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest early stage biotech investors based in the United Kingdom
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 269 contacts → | ||||
Indirect evidence “IP Group accelerates the impact of science for a better future.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 2 | 51 contacts → | ||||
Partial evidence “Nucleate is a nonprofit organisation dedicated to empowering the next generation of biotech leaders.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 3 | 43 contacts → | ||||
Indirect evidence “Northzone is a technology investment partnership.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 4 | 42 contacts → | ||||
Strong evidence “Fig provides a pragmatic new approach to supporting and investing in high-growth early-stage companies.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 5 | 37 contacts → | ||||
Indirect evidence “We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 6 | 29 contacts → | ||||
Indirect evidence “With European roots and decades of experience, we invest globally in exceptional startups and talented teams.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 7 | 28 contacts → | ||||
Indirect evidence “Abingworth is a leading transatlantic life sciences investment firm.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 8 | 24 contacts → | ||||
Indirect evidence “At Pontaq, we are dedicated to fostering cross-border investments and innovation, driving growth in startup ecosystems worldwide.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 9 | 18 contacts → | ||||
Indirect evidence “4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 10 | 18 contacts → | ||||
Indirect evidence “Our focus is to help Founders Go Further.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 11 | 15 contacts → | ||||
Partial evidence “Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 12 | 12 contacts → | ||||
Indirect evidence “Backing great companies when they’re tiny.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 13 | 9 contacts → | ||||
Partial evidence “Delin Ventures is a mission-driven investor and co-builder in two areas shaping our future: 1) With our Tech Fund, we're investing in Founders building from Germany.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 14 | 9 contacts → | ||||
Partial evidence “Supporting Innovation Early” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 15 | 8 contacts → | ||||
Strong evidence “ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 16 | 7 contacts → | ||||
Strong evidence “Martlet is EMV Capital’s early-stage Cambridge-based investment practice, focused on providing patient capital and hands-on support to deep tech and life sciences B2B startups.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 17 | 6 contacts → | ||||
Strong evidence “Osun Capital Limited is an advisor to early stage technology companies from Pre-Seed to Series B.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 18 | 5 contacts → | ||||
Indirect evidence “Probatech was founded to make sure that new opportunities in the life sciences are explored to their full potential.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 19 | 5 contacts → | ||||
Indirect evidence “NJF Capital supports innovative, industry-defining entrepreneurs pioneering the latest technological advances to make breakthroughs in fields as diverse as healthcare, FinTech…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 20 | 4 contacts → | ||||
Strong evidence “InHealth Ventures (IHV) is a London-based early stage venture capital fund investing in tech-enabled healthcare and life sciences.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 21 | 4 contacts → | ||||
Indirect evidence “Helping tech start-ups achieve more – taking your innovation to the next level to produce a commercially viable product through further development, POC trials and business plans…” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 22 | 3 contacts → | ||||
Strong evidence “Solid Bond is a pre-seed/ early seed stage investor supporting founders through this early stage of the journey.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 23 | 3 contacts → | ||||
Partial evidence “SD & K Holdings is an accelerator specialising in the biotech and healthcare sector; specific but not limited to CNS, oncology, CGT and immunology.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 24 | 3 contacts → | ||||
Partial evidence “For thirty years, the process of connecting founders with investors has relied on pitch events, personal networks, and social matching.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
| 25 | 2 contacts → | ||||
Indirect evidence “Ombu Group partners with outstanding business leaders to help them build world-class, advanced technology businesses.” Source: RevenueBase Database · checked Sep 16, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: early stage biotech investors. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names early stage biotech investors.
- Partial evidence
- Its own public description names part of early stage biotech investors, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name early stage biotech investors. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 79 early stage biotech investors based in the United Kingdom
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 230 reachable decision-makers.
Free signup · no credit card
Early stage biotech investors based in the United Kingdom at a glance
As of Sep 16, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for United Kingdom, so it is reported there. Company counts and contact totals on this page are exact for United Kingdom, over 79 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among early stage biotech investors, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in the United Kingdom whose own description of what they do matches “early stage biotech investors”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names early stage biotech investors), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among early stage biotech investors, and records with no verified work email. Companies headquartered outside United Kingdom are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 230 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 16, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Early stage biotech investors by metro
- Early stage biotech investors in London54
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names early stage biotech investors, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many early stage biotech investors are there based in the United Kingdom?
RevenueBase identified 79 early stage biotech investors headquartered in the United Kingdom as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
IP Group PLC, headquartered in London, tops this list with the largest team on record.
Which city has the most early stage biotech investors?
London leads with 54 headquartered companies, followed by Cambridge (6) and Manchester (2).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 230 verified decision-maker contacts tracked across these 79 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 16, 2026.
Ready to reach these companies? Verified emails and direct dials for all 79 early stage biotech investors based in the United Kingdom. Start with a free account, no credit card.
Download this list →Related lists
Early stage biotech investors by geography
- Early stage biotech investors based in Boston, United States
- Early stage biotech investors based in New York, United States
- Early stage biotech investors based in Palo Alto, United States
- Early stage biotech investors based in San Francisco, United States
- Early stage biotech investors based in Australia
- Early stage biotech investors based in Canada
- Early stage biotech investors based in France
- Early stage biotech investors based in Germany
- Early stage biotech investors based in India
- Early stage biotech investors based in Israel
- Early stage biotech investors based in the Netherlands
- Early stage biotech investors based in Spain
Browse the directory
Browse: Companies home · All United Kingdom lists · All Early stage biotech investors lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Early stage biotech investors based in Boston, United States
- Early stage biotech investors based in New York, United States
- Early stage biotech investors based in Palo Alto, United States
- Early stage biotech investors based in San Francisco, United States
- Early stage biotech investors based in Australia
- Early stage biotech investors based in Canada